Solution: Federal And State Policy

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Head of Federal and State Policy

ADVI Instant: CMS Releases Medicaid Drug Rebate Program Final Rule

Insights,

| Allison Schneider, MHA - Director

ADVI Analysis: MedPAC September 2024 Meeting
Events Alicia Silver Speaks at the American Society of Gene and Cell Therapy Policy Summit

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Head of Federal and State Policy

ADVI Instant: CMS Issues MFPs for the First 10 Drugs Selected for Government Negotiation
In The News Lindsay Bealor Greenleaf Interviewed by Pharmacy Times on IRA Drug Pricing Announcement
In The News Lindsay Bealor Greenleaf Discusses IRA Negotiated Drug Prices with Managed Healthcare Executive
In The News Lindsay Bealor Greenleaf Shares IRA Insights In Axios

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Head of Federal and State Policy

ADVI Instant: CMS Releases Final Part Two Guidance for the MPPP Program

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Head of Federal and State Policy

ADVI Instant: CMS Releases the FY 2025 IPPS Final Rule